RESPONSE BIOMEDICAL CORP Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent
RESPONSE BIOMEDICAL CORP had Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent of CAD 555.40 thousand as of 2012-06-30, per its 10-Q filed 2012-08-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent · last filed 2012-08-09
- 2012-06-30: Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent 555.40K CAD.
| Period end | Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent |
|---|---|
| 2012-06-30 | 555.40K CAD 10-Q · filed 2012-08-09 |